Literature DB >> 20085772

ODE models for oncolytic virus dynamics.

Natalia L Komarova1, Dominik Wodarz.   

Abstract

Replicating oncolytic viruses are able to infect and lyse cancer cells and spread through the tumor, while leaving normal cells largely unharmed. This makes them potentially useful in cancer therapy, and a variety of viruses have shown promising results in clinical trials. Nevertheless, consistent success remains elusive and the correlates of success have been the subject of investigation, both from an experimental and a mathematical point of view. Mathematical modeling of oncolytic virus therapy is often limited by the fact that the predicted dynamics depend strongly on particular mathematical terms in the model, the nature of which remains uncertain. We aim to address this issue in the context of ODE modeling, by formulating a general computational framework that is independent of particular mathematical expressions. By analyzing this framework, we find some new insights into the conditions for successful virus therapy. We find that depending on our assumptions about the virus spread, there can be two distinct types of dynamics. In models of the first type (the "fast spread" models), we predict that the viruses can eliminate the tumor if the viral replication rate is sufficiently high. The second type of models is characterized by a suboptimal spread (the "slow spread" models). For such models, the simulated treatment may fail, even for very high viral replication rates. Our methodology can be used to study the dynamics of many biological systems, and thus has implications beyond the study of virus therapy of cancers. (c) 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20085772      PMCID: PMC2839021          DOI: 10.1016/j.jtbi.2010.01.009

Source DB:  PubMed          Journal:  J Theor Biol        ISSN: 0022-5193            Impact factor:   2.691


  27 in total

1.  How should pathogen transmission be modelled?

Authors:  H McCallum; N Barlow; J Hone
Journal:  Trends Ecol Evol       Date:  2001-06-01       Impact factor: 17.712

2.  Wild-type adenovirus decreases tumor xenograft growth, but despite viral persistence complete tumor responses are rarely achieved--deletion of the viral E1b-19-kD gene increases the viral oncolytic effect.

Authors:  D Harrison; H Sauthoff; S Heitner; J Jagirdar; W N Rom; J G Hay
Journal:  Hum Gene Ther       Date:  2001-07-01       Impact factor: 5.695

Review 3.  Viruses - seeking and destroying the tumor program.

Authors:  Clodagh C O'Shea
Journal:  Oncogene       Date:  2005-11-21       Impact factor: 9.867

Review 4.  Replicating viruses as selective cancer therapeutics.

Authors:  D H Kirn; F McCormick
Journal:  Mol Med Today       Date:  1996-12

5.  Viruses as antitumor weapons: defining conditions for tumor remission.

Authors:  D Wodarz
Journal:  Cancer Res       Date:  2001-04-15       Impact factor: 12.701

Review 6.  Adenovirus-based cancer gene therapy.

Authors:  Johanne M Kaplan
Journal:  Curr Gene Ther       Date:  2005-12       Impact factor: 4.391

Review 7.  Oncolytic virotherapy for cancer treatment: challenges and solutions.

Authors:  J J Davis; B Fang
Journal:  J Gene Med       Date:  2005-11       Impact factor: 4.565

8.  Mathematical modeling of tumor therapy with oncolytic viruses: regimes with complete tumor elimination within the framework of deterministic models.

Authors:  Artem S Novozhilov; Faina S Berezovskaya; Eugene V Koonin; Georgy P Karev
Journal:  Biol Direct       Date:  2006-02-17       Impact factor: 4.540

Review 9.  From ONYX-015 to armed vaccinia viruses: the education and evolution of oncolytic virus development.

Authors:  Anne Moon Crompton; David H Kirn
Journal:  Curr Cancer Drug Targets       Date:  2007-03       Impact factor: 3.428

Review 10.  Oncolytic viruses in cancer therapy.

Authors:  Markus J V Vähä-Koskela; Jari E Heikkilä; Ari E Hinkkanen
Journal:  Cancer Lett       Date:  2007-03-23       Impact factor: 8.679

View more
  24 in total

1.  Controlling the Evolution of Resistance.

Authors:  Rutao Luo; Lamont Cannon; Jason Hernandez; Michael J Piovoso; Ryan Zurakowski
Journal:  J Process Control       Date:  2011-03-01       Impact factor: 3.666

2.  Perfusion Pressure Is a Critical Determinant of the Intratumoral Extravasation of Oncolytic Viruses.

Authors:  Amber Miller; Rebecca Nace; Camilo Ayala-Breton C; Michael Steele; Kent Bailey; Kah Whye Peng; Stephen J Russell
Journal:  Mol Ther       Date:  2015-12-09       Impact factor: 11.454

3.  Evaluating optimal therapy robustness by virtual expansion of a sample population, with a case study in cancer immunotherapy.

Authors:  Syndi Barish; Michael F Ochs; Eduardo D Sontag; Jana L Gevertz
Journal:  Proc Natl Acad Sci U S A       Date:  2017-07-17       Impact factor: 11.205

4.  Mutant Evolution in Spatially Structured and Fragmented Expanding Populations.

Authors:  Dominik Wodarz; Natalia L Komarova
Journal:  Genetics       Date:  2020-07-13       Impact factor: 4.562

Review 5.  Modeling T cell responses to antigenic challenge.

Authors:  Dominik Wodarz
Journal:  J Pharmacokinet Pharmacodyn       Date:  2014-10-01       Impact factor: 2.745

Review 6.  Kinetic Modeling of Virus Growth in Cells.

Authors:  John Yin; Jacob Redovich
Journal:  Microbiol Mol Biol Rev       Date:  2018-03-28       Impact factor: 11.056

7.  Dynamics of melanoma tumor therapy with vesicular stomatitis virus: explaining the variability in outcomes using mathematical modeling.

Authors:  D M Rommelfanger; C P Offord; J Dev; Z Bajzer; R G Vile; D Dingli
Journal:  Gene Ther       Date:  2011-09-15       Impact factor: 5.250

8.  On the laws of virus spread through cell populations.

Authors:  Dominik Wodarz; Chi N Chan; Benjamin Trinité; Natalia L Komarova; David N Levy
Journal:  J Virol       Date:  2014-09-03       Impact factor: 5.103

9.  A dynamical systems model for combinatorial cancer therapy enhances oncolytic adenovirus efficacy by MEK-inhibition.

Authors:  Neda Bagheri; Marisa Shiina; Douglas A Lauffenburger; W Michael Korn
Journal:  PLoS Comput Biol       Date:  2011-02-17       Impact factor: 4.475

10.  Mathematical modeling of viral infection dynamics in spherical organs.

Authors:  Ricardo Dunia; Roger Bonnecaze
Journal:  J Math Biol       Date:  2012-09-25       Impact factor: 2.259

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.